Prostate cancer screening for men over 70 is complex, with current recommendations against routine PSA testing due to slow ...

A powerful new drug combination—niraparib added to standard prostate cancer therapy—has been shown to significantly delay ...

A targeted drug combination delays advanced prostate cancer in men with specific DNA repair gene mutations. A large international study led by researchers at UCL has found that a new combination of dr ...

Men with recurrent prostate cancer following surgery or radiation therapy may now have a new chance to live longer. A massive ...

A globally-renowned prostate cancer surgeon shares the latest advancements in the field and stresses the importance of early detection.

However, the research team head cautioned that it is still too early to recommend the mRNA COVID-19 vaccine as a standard part of cancer therapy.

A new study underway at St. David’s Surgical Hospital could help men recover faster and live a better quality of life after ...

A powerful new drug combo has yielded a major breakthrough for men battling an aggressive form of prostate cancer, ...

Combining enzalutamide with standard hormone therapy cut the risk of prostate cancer death by over 40% in a clinical trial.